Pathological Reorganization of NMDA Receptors Subunits and Postsynaptic Protein PSD-95 Distribution in Alzheimer's Disease

Current Alzheimer Research

Volumn 11, Issue 1, 2014, Pages 86-96

  Leuba, Geneviève ^a   Vernay, André ^a   Kraftsik, Rudolf ^b   Tardif, Eric ^b   Riederer, Béat Michel ^a,b   Savioz, Armand ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Aging; Alzheimer; Cortex; GluN1; GluN2A; GluN2B; Neurons; PSD 95; Synapses

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN;

AGING; ALZHEIMER DISEASE; ARTICLE; BLADDER CARCINOMA; BRONCHOPNEUMONIA; CARCINOMA; COGNITIVE DEFECT; ENTORHINAL CORTEX; FRONTAL CORTEX; HEART FAILURE; HEART INFARCTION; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY FAILURE; LUNG EMBOLISM; MIDDLE FRONTAL GYRUS; NERVE CELL; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPIL; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; ROOM TEMPERATURE; SYNAPSE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; CEREBRAL CORTEX; ENTORHINAL CORTEX; FEMALE; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84891819579     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/15672050113106660170     Document Type: Article

References (60)

1. Tanzi RE. The synaptic Abeta hypothesis of Alzheimer disease. Nat Neurosci 8(8): 977-979 (2005).
2. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27(4): 796-807 (2007).
3. Parameshwaran K, Dhanasekaran M, Suppiramaniam V. Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol 210(1): 7-13 (2008).
4. Gong Y, Lippa CF. Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias. Am J Alzheimers Dis Other Demen 25(7): 547-555 (2010).
5. Proctor DT, Coulson EJ, Dodd PR. Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease. Prog Neurobiol 93(4): 509-521 (2011).
6. Zempel H, Mandelkow EM. Linking amyloid-beta and tau: amyloid- beta induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton. Neurodegener Dis 10(1-4): 64-72 (2012).
7. Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 5(10): 771-781 (2004).
8. Nikonenko I, Boda B, Steen S, Knott G, Welker E, Muller D. PSD- 95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling. J Cell Biol 183(6): 1115-1127 (2008).
9. Cheng HH, Liu SH, Lee HC, Lin YS, Huang ZH, Hsu CI, et al. Heavy chain of cytoplasmic dynein is a major component of the postsynaptic density fraction. J Neurosci Res 84(2): 244-254 (2006).
10. Kuriu T, Inoue A, Bito H, Sobue K, Okabe S. Differential control of postsynaptic density scaffolds via actin-dependent and - independent mechanisms. J Neurosci 26(29): 7693-7706 (2006).
11. Yoshii A, Constantine-Paton M. BDNF induces transport of PSD- 95 to dendrites through PI3K-AKT signaling after NMDA receptor activation. Nat Neurosci 10(6): 702-711 (2007).
12. Leuba G, Walzer C, Vernay A, Carnal B, Kraftsik R, Piotton F, et al. Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction. Neurobiol Dis 30(3): 408-419 (2008).
13. Leuba G, Savioz A, Vernay A, Carnal B, Kraftsik R, Tardif E, et al. Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. J Alzheimers Dis 15(1): 139-151 (2008).
14. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8(8): 1051-1058 (2005).
15. Yamin G. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. J Neurosci Res 87(8): 1729-1736 (2009).
16. Texido L, Martin-Satue M, Alberdi E, Solsona C, Matute C. Amyloid beta peptide oligomers directly activate NMDA receptors. Cell Calcium 49(3): 184-190 (2011).
17. Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA 106(10): 4012-4017 (2009).
18. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14(8): 837-842 (2008).
19. Geddes JW, Chang-Chui H, Cooper SM, Lott IT, Cotman CW. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease. Brain Res 399(1): 156-161 (1986).
20. Thorns V, Mallory M, Hansen L, Masliah E. Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer's disease and Lewy body variant. Acta Neuropathol 94(6): 539-548 (1997).
21. Ikonomovic MD, Mizukami K, Warde D, Sheffield R, Hamilton R, Wenthold RJ, et al. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease. Exp Neurol 160(1): 194-204 (1999).
22. Mishizen-Eberz AJ, Rissman RA, Carter TL, Ikonomovic MD, Wolfe BB, Armstrong DM. Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology. Neurobiol Dis 15(1): 80-92 (2004).
23. Gsell W, Jungkunz G, Riederer P. Functional neurochemistry of Alzheimer's disease. Curr Pharm Des 10(3): 265-293 (2004).
24. Magnusson KR, Brim BL, Das SR. Selective vulnerabilities of N-methyl-D-aspartate (NMDA) receptors during brain aging. Front Aging Neurosci 2(ID11): 1-11 (2010).
25. Melendez-Ferro M, Rice MW, Roberts RC, Perez-Costas E. Dual use of immunohistochemistry for film densitometry and light microscopy. J Neurosci Meth 208(1): 86-91 (2012).
26. SAS/STAT User's Guide, vol 1-2, SAS, Cary, NC, USA.
27. Mukaetova-Ladinska EB, Garcia-Siera F, Hurt J, Gertz HJ, Xuereb JH, Hills R, et al. Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol 157(2): 623-636 (2000).
28. Wang DS, Bennett DA, Mufson E, Cochran E, Dickson DW. Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly. Neurosci Lett 359(1-2): 104-108 (2004).
29. Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell W, Jr., et al. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J Alzheimers Dis 7(2): 103-117 (2005).
30. Proctor DT, Coulson EJ, Dodd PR. Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology. J Alzheimers Dis 21(3): 795-811 (2010).
31. Riederer IM, Schiffrin M, Kovari E, Bouras C, Riederer BM. Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease. Brain Res Bull 80(4-5): 233-241 (2009).
32. Riederer BM, Leuba G, Vernay A, Riederer IM. The role of the ubiquitin proteasome system in Alzheimer's disease. Exp Biol Med (Maywood) 236(3): 268-276 (2011).
33. Shao CY, Mirra SS, Sait HB, Sacktor TC, Sigurdsson EM. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Abeta and tau pathology in transgenic mouse models of Alzheimer's disease. Acta Neuropathol 122(3): 285-292 (2011).
34. Siew LK, Love S, Dawbarn D, Wilcock GK, Allen SJ. Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay. J Neurosci Meth 139(2): 153-159 (2004).
35. Love S, Siew LK, Dawbarn D, Wilcock GK, Ben-Shlomo Y, Allen SJ. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol Aging 27(6): 797-803 (2006).
36. Zhao X, Rosenke R, Kronemann D, Brim B, Das SR, Dunah AW, et al. The effects of aging on N-methyl-D-aspartate receptor subunits in the synaptic membrane and relationships to long-term spatial memory. Neurosci 162(4): 933-945 (2009).
37. Chang LR, Liu JP, Zhang N, Wang YJ, Gao XL, Wu Y. Different expression of NR2B and PSD-95 in rat hippocampal subregions during postnatal development. Microsc Res Tech 72(7): 517-524 (2009).
38. Bellone C, Nicoll RA. Rapid bidirectional switching of synaptic NMDA receptors. Neuron 55(5): 779-785 (2007).
39. van Zundert B, Yoshii A, Constantine-Paton M. Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal. Trends Neurosci 27(7): 428-437 (2004).
40. Winder DG, Schramm NL. Plasticity and behavior: new genetic techniques to address multiple forms and functions. Physiol Behav 73(5): 763-780 (2001).
41. Liu Z, Lv C, Zhao W, Song Y, Pei D, Xu T. NR2B-containing NMDA receptors expression and their relationship to apoptosis in hippocampus of Alzheimer's disease-like rats. Neurochem Res 37(7): 1420-1427 (2012).
42. Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8(6): 413-426 (2007).
43. Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol 7(8): 742-755 (2008).
44. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5(5): 405-414 (2002).
45. Petralia RS. Distribution of extrasynaptic NMDA receptors on neurons. Sci World J 2012(ID267120): 1-11 (2012).
46. Bordji K, Becerril-Ortega J, Buisson A. Synapses, NMDA receptor activity and neuronal Abeta production in Alzheimer's disease. Rev Neurosci 22(3): 285-294 (2011).
47. Danysz W, Parsons CG. Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine - searching for the connections. Br J Pharmacol 167(2): 324-352 (2012).
48. Keith D, El-Husseini A. Excitation Control: Balancing PSD-95 Function at the Synapse. Front Mol Neurosci 1(ID4): 1-12 (2008).
49. Colledge M, Snyder EM, Crozier RA, Soderling JA, Jin Y, Langeberg LK, et al. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron 40(3): 595-607 (2003).
50. Zhang J, Xu TX, Hallett PJ, Watanabe M, Grant SG, Isacson O, et al. PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex. J Neurosci 29(9): 2948-2960 (2009).
51. Kim MJ, Futai K, Jo J, Hayashi Y, Cho K, Sheng M. Synaptic accumulation of PSD-95 and synaptic function regulated by phosphorylation of serine-295 of PSD-95. Neuron 56(3): 488-502 (2007).
52. Steiner P, Higley MJ, Xu W, Czervionke BL, Malenka RC, Sabatini BL. Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity. Neuron 60(5): 788-802 (2008).
53. Schrattenholz A, Soskic V. NMDA receptors are not alone: dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol-rich membrane domains leads to disease-specific nuances of glutamate-signalling. Curr Top Med Chem 6(7): 663-686 (2006).
54. Futai K, Kim MJ, Hashikawa T, Scheiffele P, Sheng M, Hayashi Y. Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin. Nat Neurosci 10(2): 186-195 (2007).
55. Nimmrich V, Ebert U. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric betaamyloid. Rev Neurosci 20(1): 1-12 (2009).
56. Parodi J, Sepulveda FJ, Roa J, Opazo C, Inestrosa NC, Aguayo LG. Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 285(4): 2506-2514 (2010).
57. Brito-Moreira J, Paula-Lima AC, Bomfim TR, Oliveira FB, Sepulveda FJ, De Mello FG, et al. Abeta oligomers induce glutamate release from hippocampal neurons. Curr Alzheimer Res 8(5): 552-562 (2011).
58. Decker H, Jurgensen S, Adrover MF, Brito-Moreira J, Bomfim TR, Klein WL, et al. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-beta peptide oligomers. J Neurochem 115(6): 1520-1529 (2010).
59. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van EJ, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142(3): 387-397 (2010).
60. Ittner LM, Gotz J. Amyloid-beta and tau - a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12(2): 65-72 (2011).